We describe the short-term results of highly active antiretroviral therapy (HAART) in seven projects in low and middle income countries. A total of 743 adults were included, and clinical...
Laureillard D, Marcy O, Madec Y, Chea S, Chan S, et al.
2013-10-23 • AIDS
2013-10-23 • AIDS
To analyze cases of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the CAMbodian Early versus Late Introduction of Antiretrovirals (CAMELIA)...
Loarec A, Carnimeo V, Molfino L, Kizito W, Muyindike WR, et al.
2018-11-16 • AIDS
2018-11-16 • AIDS
: A multicentric, retrospective case-series analysis (facility-based) in five sites across Kenya, Malawi, Mozambique, and Uganda screened HIV-positive adults for hepatitis C virus (HCV) ...
Cornell M, Grimsrud A, Fairall L, Fox MP, van Cutsem G, et al.
2010-09-10 • AIDS
2010-09-10 • AIDS
OBJECTIVE: Little is known about the temporal impact of the rapid scale-up of large antiretroviral therapy (ART) services on programme outcomes. We describe patient outcomes [mortality, ...
Sacks JA, Fong Y, Gonzalez MP, Andreotti M, Baliga S, et al.
2019-10-01 • AIDS
2019-10-01 • AIDS
BACKGROUND Coverage of viral load testing remains low with only half of the patients in need having adequate access. Alternative technologies to high throughput centralized machines ...
We describe the short-term results of highly active antiretroviral therapy (HAART) in seven projects in low and middle income countries. A total of 743 adults were included, and clinical...
Madec Y, Szumilin E, Genevier C, Ferradini LLF, Balkan S, et al.
2009-04-27 • AIDS
2009-04-27 • AIDS
BACKGROUND In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretrovira...
Shroufi A, van Cutsem G, Cambiano V, Bansi-Matharu L, Duncan K, et al.
2019-08-01 • AIDS
2019-08-01 • AIDS
BACKGROUND Many individuals failing first-line antiretroviral therapy (ART) in sub-Saharan Africa never initiate second-line ART or do so after significant delay. For people on ART w...
Ajose O, Mookerjee S, Mills EJ, Boulle AM, Ford NP
2012-05-15 • AIDS
2012-05-15 • AIDS
A growing proportion of patients on antiretroviral therapy in resource-limited settings have switched to second-line regimens. We carried out a systematic review in order to summarize re...
Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, et al.
2006-11-28 • AIDS
2006-11-28 • AIDS
OBJECTIVES: Among adults started on antiretroviral treatment (ART) in a rural district hospital (a) to determine the cumulative proportion of deaths that occur within 3 and 6 months of s...
Boulle AM, van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, et al.
2010-02-20 • AIDS
2010-02-20 • AIDS
OBJECTIVES: We report on outcomes after 7 years of a community-based antiretroviral therapy (ART) programme in Khayelitsha, South Africa, with death registry linkages to correct for mort...
Keiser O, Tweya H, Boulle AM, Braitstein P, Schechter M, et al.
2009-09-10 • AIDS
2009-09-10 • AIDS
BACKGROUND In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring ...
Coetzee D, Hildebrand K, Boulle AM, Maartens G, Louis F, et al.
2004-04-09 • AIDS
2004-04-09 • AIDS
BACKGROUND A community-based antiretroviral therapy (ART) programme was established in 2001 in a South African township to explore the operational issues involved in providing ART in...
Coetzee D, Boulle AM, Hildebrand K, Asselman V, van Cutsem G, et al.
2004-06-01 • AIDS
2004-06-01 • AIDS
OBJECTIVE To describe the approach used to promote adherence to antiretroviral therapy (ART) and to present the outcomes in the first primary care public sector ART project in South ...
OBJECTIVES To (a) determine early treatment outcomes and (b) assess safety in children treated with adult fixed-dose combination (FDC) antiretroviral tablets.
